Keymed Biosciences (2162.HK) Q1 2026 Earnings

26MarConfirmed
Q3 2024
Q1 2025
Q3 2025
Q1 2026
-1.8
-1.31
-0.82
-0.33

Details

Expected EPS
-1.465464074984
Actual EPS
-1.7954731605720002
Surprise EPS
-0.33
Surprise Percent
+22.52%

Description

Keymed Biosciences (2162.HK) has reported earnings of -1.7954731605720002 per share for Q1 2026.

0 Comments

Share your thoughts